新西兰男子成为中国首位接受实体瘤CAR-T治疗的外国患者
- When
- 2026-08
- City
- Shanghai
- 自报总费用
- about $139,436.62 (as reported)
- Shared on
- News
- Patient from
- New Zealand
有报道最后核验
时间线
2026-06
China's NMPA approves the first CAR-T therapy for a solid tumor.
2026-07
Flies to Shanghai with his wife and son after doctors at home said treatment had failed.
2026-08-16
Ends a six-week treatment journey and flies home.
顺利之处
- 获得了本国尚无法提供的疗法
困难之处
- 单次CAR-T输注费用为990,000元人民币（据消息来源约合137,000美元）
- 治疗前身体十分虚弱
Individual experience; outcomes vary. This story is a summary linking to its source; follow the link for the original account.
来源
本站仅提供信息，不构成医疗建议、诊断或治疗推荐。请咨询你的医生。紧急情况请立即拨打当地急救电话。